Abstract |
The clinical outcome and tolerability following treatment with samarium-153 particulate hydroxyapatite was evaluated in patients with persistent rheumatoid knee synovitis. The clinical review of 18 patients treated with intra-articular samarium-153 particulate hydroxyapatite combined with triamcinolone hexacetonide who had failed to obtain more than 4 weeks symptom relief from a prior intra-articular glucocorticoid injection was undertaken. No unwanted effects from the treatment were observed. Symptom relief was maintained in 56% patients at 6 months and in 44% of patients at 12 months following treatment. Median duration of symptom relief was 9 months. There was a significantly higher mean baseline Ritchie Articular Index in patients relapsing within 3 months and a trend towards earlier relapse in patients with higher indices of disease activity at the time of treatment. There was a trend towards earlier relapse in patients with a poor range of knee flexion at baseline and with worse indices of intra-articular radiopharmaceutical distribution. Samarium-153 particulate hydroxyapatite knee synovectomy is well tolerated and may be an effective treatment for carefully selected patients with persistent rheumatoid knee synovitis.
|
Authors | G Clunie, D Lui, I Cullum, P J Ell, J C Edwards |
Journal | Scandinavian journal of rheumatology
(Scand J Rheumatol)
Vol. 25
Issue 6
Pg. 360-6
( 1996)
ISSN: 0300-9742 [Print] England |
PMID | 8996470
(Publication Type: Journal Article)
|
Chemical References |
- Hydroxyapatites
- Radioisotopes
- samarium hydroxyapatite
- Samarium
|
Topics |
- Adult
- Aged
- Arthritis, Rheumatoid
(complications, drug therapy)
- Female
- Humans
- Hydroxyapatites
(administration & dosage, therapeutic use)
- Injections, Intra-Articular
- Knee Joint
- Male
- Middle Aged
- Radioisotopes
(administration & dosage, therapeutic use)
- Recurrence
- Samarium
(administration & dosage, therapeutic use)
- Synovitis
(complications, drug therapy)
- Treatment Outcome
|